两家公司表示,在合作的初始阶段,Ares开发了一个数字抗感染平台,将微生物学实验室实践与先进的生物信息学和人工智能方法相结合,以帮助识别有效的抗菌化合物...查看全文
蹊之美股生物医药2021-10-08 00:15
作者:林出
微信公众号:蹊之美股生物医药 / CaesarBiotech
Gainers:
Voyager Therapeutics (NASDAQ:VYGR) +56%
Acer Therapeutics (NASDAQ:ACER) +16%
Molecular Partners (NASDAQ:MOLN) +10%
Rafael (NYSE:RFL) +6%
Arcturus Therapeutics (NASDA...查看全文
东哥_Singapore2021-03-08 23:42
$Jaguar Health(JAGX)$ 给力点啊,速度冲2.5!刚才在2.9的OPGN跟1.85的你之间,最后选的你!不要让我失望啊!OPGN已经爆拉了!!!$OpGen(OPGN)$查看全文
$OpGen(OPGN)$ 8-K Current report, items 8.01 and 9.01 Accession Number: 0001079973-20-000125 Act: 34 Size: 49 KB 网页链接
$OpGen(OPGN)$ 8-K Current report, items 8.01 and 9.01 Accession Number: 0001079973-20-000106 Act: 34 Size: 55 KB 网页链接
$OpGen(OPGN)$ 8-K Current report, items 1.01 and 9.01 Accession Number: 0001079973-20-000103 Act: 34 Size: 268 KB 网页链接
$OpGen(OPGN)$ 424B5 Prospectus [Rule 424(b)(5)] Accession Number: 0001079973-20-000101 Act: 33 Size: 2 MB 网页链接
$OpGen(OPGN)$ SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals Accession Number: 0001104659-20-013420 Act: 34 Size: 86 KB 网页链接
$OpGen(OPGN)$ EFFECT Notice of Effectiveness Accession Number: 9999999995-20-000294 Act: 33 Size: 1 KB 网页链接
$OpGen(OPGN)$ S-3/A [Amend] Registration statement under Securities Act of 1933 Accession Number: 0001079973-20-000083 Act: 33 Size: 2 MB 网页链接
$OpGen(OPGN)$ 8-K Current report, items 8.01 and 9.01 Accession Number: 0001079973-20-000070 Act: 34 Size: 66 KB 网页链接
$OpGen(OPGN)$ S-3 Registration statement under Securities Act of 1933 Accession Number: 0001079973-20-000068 Act: 33 Size: 2 MB 网页链接
$OpGen(OPGN)$ DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material Accession Number: 0001079973-20-000059 Act: 34 Size: 28 KB 网页链接